Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 2
2010 1
2016 1
2017 2
2018 1
2019 1
2020 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

9 results
Results by year
Filters applied: . Clear all
Page 1
The pediatric preclinical testing program: description of models and early testing results.
Houghton PJ, Morton CL, Tucker C, Payne D, Favours E, Cole C, Gorlick R, Kolb EA, Zhang W, Lock R, Carol H, Tajbakhsh M, Reynolds CP, Maris JM, Courtright J, Keir ST, Friedman HS, Stopford C, Zeidner J, Wu J, Liu T, Billups CA, Khan J, Ansher S, Zhang J, Smith MA. Houghton PJ, et al. Among authors: favours e. Pediatr Blood Cancer. 2007 Dec;49(7):928-40. doi: 10.1002/pbc.21078. Pediatr Blood Cancer. 2007. PMID: 17066459
Evaluation of patritumab with or without erlotinib in combination with standard cytotoxic agents against pediatric sarcoma xenograft models.
Bandyopadhyay A, Favours E, Phelps DA, Pozo VD, Ghilu S, Kurmashev D, Michalek J, Trevino A, Guttridge D, London C, Hirotani K, Zhang L, Kurmasheva RT, Houghton PJ. Bandyopadhyay A, et al. Among authors: favours e. Pediatr Blood Cancer. 2018 Feb;65(2):10.1002/pbc.26870. doi: 10.1002/pbc.26870. Epub 2017 Oct 28. Pediatr Blood Cancer. 2018. PMID: 29080385 Free PMC article.
Evaluation of ABT-751 against childhood cancer models in vivo.
Morton CL, Favours EG, Mercer KS, Boltz CR, Crumpton JC, Tucker C, Billups CA, Houghton PJ. Morton CL, et al. Among authors: favours eg. Invest New Drugs. 2007 Aug;25(4):285-95. doi: 10.1007/s10637-007-9042-y. Epub 2007 Mar 24. Invest New Drugs. 2007. PMID: 17384918